Microarray gene expression analysis of murine tumor heterogeneity defined by dynamic contrast-enhanced MRI

Nick G. Costouros, Dominique Lorang, Yantian Zhang, Marshall S. Miller, Felix E. Diehn, Stephen M. Hewitt, Michael V. Knopp, King C P Li, Peter L. Choyke, H. Richard Alexander, Steven K. Libutti

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Current methods of studying angiogenesis are limited In their ability to serially evaluate In vivo function throughout a target tissue. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and pharmacokinetic modeling provide a useful method for evaluating tissue vasculature based on contrast accumulation and washout. While it is often assumed that areas of high contrast enhancement and washout comprise areas of Increased angiogenesis and tumor activity, the actual molecular pathways that are active in such areas are poorly understood. Using DCE-MRI in a murine subcutaneous tumor model, we were able to perform pharmacokinetic functional analysis of a tumor, coregistration of MRI images with histological cross-sections, immunohistochemistry, laser capture microdissection, and genetic profiling of tumor heterogeneity based on pharmacokinetic parameters. Using imaging as a template for biologic investigation, we have not found evidence of increased expression of proangiogenic modulators at the transcriptional level in either distinct pharmacokinetic region. Furthermore, these regions show no difference on histology and CD31 immunohistochemistry. However, the expression of ribosomal proteins was greatly increased in high enhancement and washout regions, implying increased protein translation and consequent increased cellular activity. Together, these findings point to the potential importance of posttranscriptional regulation in angiogenesis and the need for the development of angiogenesis-specific contrast agents to evaluate in vivo angiogenesis at a molecular level.

Original languageEnglish (US)
Pages (from-to)301-308
Number of pages8
JournalMolecular Imaging
Volume1
Issue number3
DOIs
StatePublished - Jul 2002
Externally publishedYes

Fingerprint

Pharmacokinetics
Microarrays
Gene expression
Magnetic resonance imaging
Tumors
Gene Expression
Magnetic resonance
Imaging techniques
Neoplasms
Microdissection
Immunohistochemistry
Magnetic Resonance Imaging
Tissue
Laser Capture Microdissection
Proteins
Functional analysis
Histology
Ribosomal Proteins
Protein Biosynthesis
Contrast Media

Keywords

  • Gadolinium
  • Gene expression
  • Laser capture microdissection
  • Magnetic resonance imaging
  • Microarray

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Costouros, N. G., Lorang, D., Zhang, Y., Miller, M. S., Diehn, F. E., Hewitt, S. M., ... Libutti, S. K. (2002). Microarray gene expression analysis of murine tumor heterogeneity defined by dynamic contrast-enhanced MRI. Molecular Imaging, 1(3), 301-308. https://doi.org/10.1162/153535002760235481

Microarray gene expression analysis of murine tumor heterogeneity defined by dynamic contrast-enhanced MRI. / Costouros, Nick G.; Lorang, Dominique; Zhang, Yantian; Miller, Marshall S.; Diehn, Felix E.; Hewitt, Stephen M.; Knopp, Michael V.; Li, King C P; Choyke, Peter L.; Alexander, H. Richard; Libutti, Steven K.

In: Molecular Imaging, Vol. 1, No. 3, 07.2002, p. 301-308.

Research output: Contribution to journalArticle

Costouros, NG, Lorang, D, Zhang, Y, Miller, MS, Diehn, FE, Hewitt, SM, Knopp, MV, Li, KCP, Choyke, PL, Alexander, HR & Libutti, SK 2002, 'Microarray gene expression analysis of murine tumor heterogeneity defined by dynamic contrast-enhanced MRI', Molecular Imaging, vol. 1, no. 3, pp. 301-308. https://doi.org/10.1162/153535002760235481
Costouros, Nick G. ; Lorang, Dominique ; Zhang, Yantian ; Miller, Marshall S. ; Diehn, Felix E. ; Hewitt, Stephen M. ; Knopp, Michael V. ; Li, King C P ; Choyke, Peter L. ; Alexander, H. Richard ; Libutti, Steven K. / Microarray gene expression analysis of murine tumor heterogeneity defined by dynamic contrast-enhanced MRI. In: Molecular Imaging. 2002 ; Vol. 1, No. 3. pp. 301-308.
@article{33e9d612b77c4550b21c630591c86bcf,
title = "Microarray gene expression analysis of murine tumor heterogeneity defined by dynamic contrast-enhanced MRI",
abstract = "Current methods of studying angiogenesis are limited In their ability to serially evaluate In vivo function throughout a target tissue. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and pharmacokinetic modeling provide a useful method for evaluating tissue vasculature based on contrast accumulation and washout. While it is often assumed that areas of high contrast enhancement and washout comprise areas of Increased angiogenesis and tumor activity, the actual molecular pathways that are active in such areas are poorly understood. Using DCE-MRI in a murine subcutaneous tumor model, we were able to perform pharmacokinetic functional analysis of a tumor, coregistration of MRI images with histological cross-sections, immunohistochemistry, laser capture microdissection, and genetic profiling of tumor heterogeneity based on pharmacokinetic parameters. Using imaging as a template for biologic investigation, we have not found evidence of increased expression of proangiogenic modulators at the transcriptional level in either distinct pharmacokinetic region. Furthermore, these regions show no difference on histology and CD31 immunohistochemistry. However, the expression of ribosomal proteins was greatly increased in high enhancement and washout regions, implying increased protein translation and consequent increased cellular activity. Together, these findings point to the potential importance of posttranscriptional regulation in angiogenesis and the need for the development of angiogenesis-specific contrast agents to evaluate in vivo angiogenesis at a molecular level.",
keywords = "Gadolinium, Gene expression, Laser capture microdissection, Magnetic resonance imaging, Microarray",
author = "Costouros, {Nick G.} and Dominique Lorang and Yantian Zhang and Miller, {Marshall S.} and Diehn, {Felix E.} and Hewitt, {Stephen M.} and Knopp, {Michael V.} and Li, {King C P} and Choyke, {Peter L.} and Alexander, {H. Richard} and Libutti, {Steven K.}",
year = "2002",
month = "7",
doi = "10.1162/153535002760235481",
language = "English (US)",
volume = "1",
pages = "301--308",
journal = "Molecular Imaging",
issn = "1535-3508",
publisher = "Decker Publishing",
number = "3",

}

TY - JOUR

T1 - Microarray gene expression analysis of murine tumor heterogeneity defined by dynamic contrast-enhanced MRI

AU - Costouros, Nick G.

AU - Lorang, Dominique

AU - Zhang, Yantian

AU - Miller, Marshall S.

AU - Diehn, Felix E.

AU - Hewitt, Stephen M.

AU - Knopp, Michael V.

AU - Li, King C P

AU - Choyke, Peter L.

AU - Alexander, H. Richard

AU - Libutti, Steven K.

PY - 2002/7

Y1 - 2002/7

N2 - Current methods of studying angiogenesis are limited In their ability to serially evaluate In vivo function throughout a target tissue. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and pharmacokinetic modeling provide a useful method for evaluating tissue vasculature based on contrast accumulation and washout. While it is often assumed that areas of high contrast enhancement and washout comprise areas of Increased angiogenesis and tumor activity, the actual molecular pathways that are active in such areas are poorly understood. Using DCE-MRI in a murine subcutaneous tumor model, we were able to perform pharmacokinetic functional analysis of a tumor, coregistration of MRI images with histological cross-sections, immunohistochemistry, laser capture microdissection, and genetic profiling of tumor heterogeneity based on pharmacokinetic parameters. Using imaging as a template for biologic investigation, we have not found evidence of increased expression of proangiogenic modulators at the transcriptional level in either distinct pharmacokinetic region. Furthermore, these regions show no difference on histology and CD31 immunohistochemistry. However, the expression of ribosomal proteins was greatly increased in high enhancement and washout regions, implying increased protein translation and consequent increased cellular activity. Together, these findings point to the potential importance of posttranscriptional regulation in angiogenesis and the need for the development of angiogenesis-specific contrast agents to evaluate in vivo angiogenesis at a molecular level.

AB - Current methods of studying angiogenesis are limited In their ability to serially evaluate In vivo function throughout a target tissue. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and pharmacokinetic modeling provide a useful method for evaluating tissue vasculature based on contrast accumulation and washout. While it is often assumed that areas of high contrast enhancement and washout comprise areas of Increased angiogenesis and tumor activity, the actual molecular pathways that are active in such areas are poorly understood. Using DCE-MRI in a murine subcutaneous tumor model, we were able to perform pharmacokinetic functional analysis of a tumor, coregistration of MRI images with histological cross-sections, immunohistochemistry, laser capture microdissection, and genetic profiling of tumor heterogeneity based on pharmacokinetic parameters. Using imaging as a template for biologic investigation, we have not found evidence of increased expression of proangiogenic modulators at the transcriptional level in either distinct pharmacokinetic region. Furthermore, these regions show no difference on histology and CD31 immunohistochemistry. However, the expression of ribosomal proteins was greatly increased in high enhancement and washout regions, implying increased protein translation and consequent increased cellular activity. Together, these findings point to the potential importance of posttranscriptional regulation in angiogenesis and the need for the development of angiogenesis-specific contrast agents to evaluate in vivo angiogenesis at a molecular level.

KW - Gadolinium

KW - Gene expression

KW - Laser capture microdissection

KW - Magnetic resonance imaging

KW - Microarray

UR - http://www.scopus.com/inward/record.url?scp=0013062527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0013062527&partnerID=8YFLogxK

U2 - 10.1162/153535002760235481

DO - 10.1162/153535002760235481

M3 - Article

VL - 1

SP - 301

EP - 308

JO - Molecular Imaging

JF - Molecular Imaging

SN - 1535-3508

IS - 3

ER -